Does UPADACITINIB Cause Thrombosis? 549 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 549 reports of Thrombosis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.8% of all adverse event reports for UPADACITINIB.
549
Reports of Thrombosis with UPADACITINIB
0.8%
of all UPADACITINIB reports
11
Deaths
221
Hospitalizations
How Dangerous Is Thrombosis From UPADACITINIB?
Of the 549 reports, 11 (2.0%) resulted in death, 221 (40.3%) required hospitalization, and 7 (1.3%) were considered life-threatening.
Is Thrombosis Listed in the Official Label?
Yes, Thrombosis is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Thrombosis?
LENALIDOMIDE (6,433)
APIXABAN (5,298)
RIVAROXABAN (3,220)
ADALIMUMAB (2,334)
POMALIDOMIDE (1,158)
TOFACITINIB (1,143)
RITUXIMAB (1,083)
ETANERCEPT (1,051)
METHOTREXATE (981)
PREDNISONE (963)
Which UPADACITINIB Alternatives Have Lower Thrombosis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL